✦ LIBER ✦
Anatibant®, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury
✍ Scribed by Klaus Zweckberger; Nikolaus Plesnila
- Book ID
- 116771190
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 207 KB
- Volume
- 454
- Category
- Article
- ISSN
- 0304-3940
No coin nor oath required. For personal study only.